A council chaired by President Obama has called for countries to cooperate to investigate the potential uses of artificial intelligence in healthcare.

Elemental Machines is shipping its sensor-enabled smart lab system to cut the time it takes to pinpoint causes of variability and reproducibility problems.

Amadeus Capital and Jonathan Milner have teamed up to invest in Healx, a startup working with patient advocacy groups to repurpose drugs for rare diseases.

Recursion Pharmaceuticals has raised $12.9 million to scale up its computer-driven approach to drug development.

British startup BenevolentAI has become the first European firm to install a purpose-built version of the DGX-1, a supercomputer designed for deep learning.

Antidote, the tech startup formerly known as TrialReach, is gearing up to introduce a tool to automatically match patients’ EHRs to clinical trials.

AOBiome is running an iPhone-enabled Phase IIb trial of its bacterial treatment for acne with Novartis ($NVS)-backed virtual trial CRO Science 37.

Researchers have found 110 antiviral targets and several existing drugs that may hit them using gene-trap insertional mutagenesis and a computational framework…

In a recent effort to characterize new targets of obesity, a collaborative effort has suggested a new mechanism that regulates obesity in the mouse’s brain.

R&D